Franklin Genomic Advancements ETF (HELX)
Snapshot
- 1 week
- -1.3%-0.6% vs SPY
- 1 month
- +2.4%+2.8% vs SPY
- Assets
- $35.9M
- Expense ratio
- 0.50%
- Fund type
- EQUITY
- Distribution yield
- 0.32%
Signal evidence
Prediction markets
Kalshi · Polymarket · … linked
Fund
Franklin Genomic Advancements ETF (HELX). This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as those operating in international markets, encompassing both established and emerging economies. The core investment thesis of the fund centers on companies engaged in genomic advancements. Specifically, it seeks out firms that the investment manager believes are fundamentally ded…
Snapshot
Price & returns1 month +2.4%
- 1 week
- -1.3%-0.6% vs SPY
- 1 month
- +2.4%+2.8% vs SPY
FundAssets $35.9M · Expense ratio 0.50%
- Assets
- $35.9M
- Expense ratio
- 0.50%
- Fund type
- EQUITY
IncomeYield 0.32%
- Distribution yield
- 0.32%
Signal evidence
Prediction markets
Kalshi · Polymarket · … linked
Fund
Franklin Genomic Advancements ETF (HELX). This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as those operating in international markets, encompassing both established and emerging economies. The core investment thesis of the fund centers on companies engaged in genomic advancements. Specifically, it seeks out firms that the investment manager believes are fundamentally ded…
Company news
Loading headlines…